Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Development of an Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment Based on Multimodal Data Fusion Using Deep Learning Technology

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

To improve the accuracy of risk prediction, screening and treatment outcome of cancer, we aim to establish a medical database that includes standardized and structured clinical diagnosis and treatment information, image features, pathological features, and multi-omics information and to develop a multi-modal data fusion-based technology system using artificial intelligence technology based on database.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Participants with the suspected of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision

• Participants that have signed informed consent.

• Participants with detailed electronic medical records, image records, pathological records, multi-omics information, and other important clinical diagnostic information.

• Healthy participants with no clinical diagnosis of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision.

Locations
Other Locations
China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Yang Jin
whuhjy@126.com
15107177084
Time Frame
Start Date: 2022-06-01
Estimated Completion Date: 2026-10
Participants
Target number of participants: 3000
Treatments
Lung cancer group
Participants with lung cancer/pulmonary nodules
Stomach cancer group
Participants with Stomach cancer/Stomach lesion
Colorectal cancer group
Participants with Colorectal cancer/Colorectal lesion
Sponsors
Leads: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

This content was sourced from clinicaltrials.gov